Enhanced engagement of CTLA-4 induces antigen-specific CD4+ CD25+ Foxp3+ and CD4+ CD25− TGF-β1+ adaptive regulatory T cells

R Li, N Perez, S Karumuthil-Melethil… - The Journal of …, 2007 - journals.aai.org
R Li, N Perez, S Karumuthil-Melethil, BS Prabhakar, MJ Holterman, C Vasu
The Journal of Immunology, 2007journals.aai.org
CTLA-4 is a critical negative regulator of T cell response and is instrumental in maintaining
immunological tolerance. In this article, we report that enhanced selective engagement of
CTLA-4 on T cells by Ag-presenting dendritic cells resulted in the induction of Ag-specific
CD4+ CD25+ Foxp3+ and CD4+ CD25− TGF-β1+ adaptive Tregs. These cells were CD62L
low and hyporesponsive to stimulation with cognate Ag but demonstrated a superior ability
to suppress Ag-specific effector T cell response compared with their CD62L high …
Abstract
CTLA-4 is a critical negative regulator of T cell response and is instrumental in maintaining immunological tolerance. In this article, we report that enhanced selective engagement of CTLA-4 on T cells by Ag-presenting dendritic cells resulted in the induction of Ag-specific CD4+ CD25+ Foxp3+ and CD4+ CD25− TGF-β1+ adaptive Tregs. These cells were CD62L low and hyporesponsive to stimulation with cognate Ag but demonstrated a superior ability to suppress Ag-specific effector T cell response compared with their CD62L high counterparts. Importantly, treatment of mice with autoimmune thyroiditis using mouse thyroglobulin (mTg)-pulsed anti-CTLA-4 agonistic Ab-coated DCs, which results in a dominant engagement of CTLA-4 upon self-Ag presentation, not only suppressed thyroiditis but also prevented reemergence of the disease upon rechallenge with mTg. Further, the disease suppression was associated with significantly reduced mTg-specific T cell and Ab responses. Collectively, our results showed an important role for selective CTLA-4 signaling in the induction of adaptive Tregs and suggested that approaches that allow dominant CTLA-4 engagement concomitant with Ag-specific TCR ligation can be used for targeted therapy.
journals.aai.org